Personal genome medicine: the legal and regulatory transformation of US medicine
"The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and pre...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, United Kingdom ; New York, NY ; Port Melbourne ; New Delhi ; Singapore
Cambridge University Press
2023
|
Schlagworte: | |
Zusammenfassung: | "The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"-- |
Beschreibung: | xiii, 464 Seiten Diagramm 24 cm |
ISBN: | 9781009293327 100929332X 9781009293365 1009293362 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV049484338 | ||
003 | DE-604 | ||
005 | 20240531 | ||
007 | t | ||
008 | 240103s2023 |||| b||| 00||| eng d | ||
020 | |a 9781009293327 |c Hardback |9 978-1-009-29332-7 | ||
020 | |a 100929332X |9 1-009-29332-X | ||
020 | |a 9781009293365 |c Paperback |9 978-1-009-29336-5 | ||
020 | |a 1009293362 |9 1-009-29336-2 | ||
035 | |a (DE-599)BVBBV049484338 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-M382 | ||
100 | 1 | |a Malinowski, Michael J. |e Verfasser |0 (DE-588)1331333156 |4 aut | |
245 | 1 | 0 | |a Personal genome medicine |b the legal and regulatory transformation of US medicine |c Michael J. Malinowski, Louisiana State University |
264 | 1 | |a Cambridge, United Kingdom ; New York, NY ; Port Melbourne ; New Delhi ; Singapore |b Cambridge University Press |c 2023 | |
300 | |a xiii, 464 Seiten |b Diagramm |c 24 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
505 | 8 | |a Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine | |
520 | 3 | |a "The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"-- | |
653 | 0 | |a Medical genetics / Law and legislation / United States | |
653 | 0 | |a Medical genetics / Law and legislation | |
653 | 2 | |a United States | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-009-29334-1 |
Datensatz im Suchindex
_version_ | 1805074721921826816 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Malinowski, Michael J. |
author_GND | (DE-588)1331333156 |
author_facet | Malinowski, Michael J. |
author_role | aut |
author_sort | Malinowski, Michael J. |
author_variant | m j m mj mjm |
building | Verbundindex |
bvnumber | BV049484338 |
contents | Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine |
ctrlnum | (DE-599)BVBBV049484338 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV049484338</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240531</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">240103s2023 |||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009293327</subfield><subfield code="c">Hardback</subfield><subfield code="9">978-1-009-29332-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">100929332X</subfield><subfield code="9">1-009-29332-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009293365</subfield><subfield code="c">Paperback</subfield><subfield code="9">978-1-009-29336-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1009293362</subfield><subfield code="9">1-009-29336-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049484338</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Malinowski, Michael J.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1331333156</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Personal genome medicine</subfield><subfield code="b">the legal and regulatory transformation of US medicine</subfield><subfield code="c">Michael J. Malinowski, Louisiana State University</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, United Kingdom ; New York, NY ; Port Melbourne ; New Delhi ; Singapore</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiii, 464 Seiten</subfield><subfield code="b">Diagramm</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"--</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical genetics / Law and legislation / United States</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical genetics / Law and legislation</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-009-29334-1</subfield></datafield></record></collection> |
id | DE-604.BV049484338 |
illustrated | Not Illustrated |
index_date | 2024-07-03T23:18:38Z |
indexdate | 2024-07-20T05:30:01Z |
institution | BVB |
isbn | 9781009293327 100929332X 9781009293365 1009293362 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034829754 |
open_access_boolean | |
owner | DE-M382 |
owner_facet | DE-M382 |
physical | xiii, 464 Seiten Diagramm 24 cm |
publishDate | 2023 |
publishDateSearch | 2023 |
publishDateSort | 2023 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Malinowski, Michael J. Verfasser (DE-588)1331333156 aut Personal genome medicine the legal and regulatory transformation of US medicine Michael J. Malinowski, Louisiana State University Cambridge, United Kingdom ; New York, NY ; Port Melbourne ; New Delhi ; Singapore Cambridge University Press 2023 xiii, 464 Seiten Diagramm 24 cm txt rdacontent n rdamedia nc rdacarrier Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine "The United States' decentralized, largely privatized, and commerce-driven healthcare system is undergoing a shift to personal genome medicine. This change is charged by ongoing progress in biotech and genomic research and development. This book draws from U.S. medicine's past and present to address its emerging personal genome medicine future"-- Medical genetics / Law and legislation / United States Medical genetics / Law and legislation United States Erscheint auch als Online-Ausgabe 978-1-009-29334-1 |
spellingShingle | Malinowski, Michael J. Personal genome medicine the legal and regulatory transformation of US medicine Prologue. Revolution, transition, and transformation -- Medical profession sovereignty to protect and promote the science and evidence base of US medicine -- US integration of government, academia, and industry : a catalyst for science-technology revolutions -- The proliferation of US direct-to-consumer (DTC) and direct-to-physician (DTP) biopharmaceutical marketing -- The evolution of consumer genetic testing services from Oncormed, Inc. to 23andMe Holding Co. -- Vulnerability of the science and evidence base of US medicine -- A warning label for commercial direct-to-consumer (DTC) genetics -- Protecting and promoting the evidentiary-science base of personal genome medicine (PGM) epilogue. the personal genome future of US medicine |
title | Personal genome medicine the legal and regulatory transformation of US medicine |
title_alt | Personal genome medicine |
title_auth | Personal genome medicine the legal and regulatory transformation of US medicine |
title_exact_search | Personal genome medicine the legal and regulatory transformation of US medicine |
title_exact_search_txtP | Personal genome medicine the legal and regulatory transformation of US medicine |
title_full | Personal genome medicine the legal and regulatory transformation of US medicine Michael J. Malinowski, Louisiana State University |
title_fullStr | Personal genome medicine the legal and regulatory transformation of US medicine Michael J. Malinowski, Louisiana State University |
title_full_unstemmed | Personal genome medicine the legal and regulatory transformation of US medicine Michael J. Malinowski, Louisiana State University |
title_short | Personal genome medicine |
title_sort | personal genome medicine the legal and regulatory transformation of us medicine |
title_sub | the legal and regulatory transformation of US medicine |
work_keys_str_mv | AT malinowskimichaelj personalgenomemedicinethelegalandregulatorytransformationofusmedicine |